Daniel P. O'Day - Mar 10, 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Stock symbol
GILD
Transactions as of
Mar 10, 2024
Transactions value $
-$1,035,304
Form type
4
Date filed
3/11/2024, 09:11 PM
Previous filing
Feb 2, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +10.8K +2.3% 479K Mar 10, 2024 Direct F1
transaction GILD Common Stock Options Exercise +19.1K +3.99% 499K Mar 10, 2024 Direct F1
transaction GILD Common Stock Tax liability -$1.04M -13.8K -2.76% $75.12 485K Mar 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -10.8K -9.74% 100K Mar 10, 2024 Common Stock 10.8K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -19.1K -19.12% 81K Mar 10, 2024 Common Stock 19.1K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +279K $0.00 279K Mar 10, 2024 Common Stock 279K $75.12 Direct F4
transaction GILD Restricted Stock Unit Award +54.9K +67.83% 136K Mar 10, 2024 Common Stock 54.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The options have a four-year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.